Impress, a Barcelona-based clear-aligner and healthtech company, featured in several updates this week highlighting both its operational strategy and external recognition. The company emphasized its use of digital workflows and AI-driven monitoring to scale doctor-led orthodontic care across its multi-clinic network.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Impress reported that its medical leadership, including co-founder and Chief Orthodontist Khaled Kasem, participated in the 2026 Invisalign EMEA Ortho Summit in Barcelona. The company underlined its reliance on Align Technology’s iTero and ClinCheck platforms as a digital backbone for integrated treatment planning.
Management framed these digital tools as critical to achieving consistency, quality control, and scalability, particularly as it expands across EMEA markets. By standardizing clinical protocols through technology, Impress aims to increase capacity utilization while maintaining personalized treatment.
The company also highlighted AI-enabled patient monitoring as a way to extend doctors’ reach and support safer, more efficient care. This technology-centric operating model is presented as more scalable than traditional orthodontic practices, with potential benefits for margins as the clinic network grows.
Separately, Impress announced it has been included in Sifted’s ranking of the fastest-growing startups in Southern Europe. The recognition is attributed to several years of expansion and a hybrid care model that blends in-person and remote orthodontic treatment.
Impress reiterated its ambition to be Europe’s largest clear-aligner-focused brand and an early AI adopter in orthodontics. While no financial metrics or new funding details were disclosed, the company suggested that its positioning could support continued patient growth and strengthen competitive differentiation.
The posts also placed Impress within a broader Southern European ecosystem of AI-driven companies, citing commentary on the region’s strengths in AI talent and research. Barcelona’s growing status as a technology hub, with multiple high-growth startups, was presented as supportive for recruitment, partnerships, and scaling healthtech operations.
Taken together, this week’s updates portray Impress as leaning heavily into digital platforms, AI, and ecosystem advantages to underpin its growth strategy. The developments point to a focus on scalable, technology-enabled orthodontic care and external validation of its expansion trajectory, albeit without concrete financial disclosures.